FHC
EDIT icon

First Horizon Corporation’s Editas Medicine EDIT Stock Holding History

First Horizon Corporation’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-300
Closed -$12K – 1105
2021
Q1 		$12K Sell
300
-200
-40% -$11.4K ﹤0.01% 637
2020
Q4 		$35K Hold
500
– – ﹤0.01% 409
2020
Q3 		$14K Buy
+500
New +$16.3K ﹤0.01% 553

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

First Horizon Corporation's EDIT Position: Q2 2021 in Review

First Horizon Corporation sold out of Editas Medicine (EDIT) in Q2 2021, closing a stake of 300 shares — an estimated $12K sold.

First Horizon Corporation first reported a position in EDIT in Q3 2020 and held it in 3 quarters. The position peaked at $35K in Q4 2020. 313 funds tracked by Wall St. Rank hold EDIT as of Q2 2021.

  • First Horizon Corporation reported no remaining Editas Medicine position as of Q2 2021 after selling out during the quarter.
  • First Horizon Corporation sold 300 Editas Medicine shares in Q2 2021, an estimated $12K.
  • First Horizon Corporation first reported a position in Editas Medicine in Q3 2020 and held it in 3 quarters.
  • First Horizon Corporation's Editas Medicine position peaked at $35K in Q4 2020.
  • 313 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2021.

Based on First Horizon Corporation's 13F filing for Q2 2021, filed 9 Aug 2021.